HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hsiang-Fu Kung Selected Research

WeiJia

3/2006Effect of WeiJia on carbon tetrachloride induced chronic liver injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hsiang-Fu Kung Research Topics

Disease

64Neoplasms (Cancer)
01/2019 - 06/2002
17Hepatocellular Carcinoma (Hepatoma)
01/2018 - 06/2002
16Carcinoma (Carcinomatosis)
01/2019 - 06/2002
15Carcinogenesis
10/2015 - 08/2004
14Neoplasm Metastasis (Metastasis)
01/2019 - 05/2006
13Glioblastoma (Glioblastoma Multiforme)
01/2018 - 06/2007
11Glioma (Gliomas)
01/2018 - 06/2007
11Infections
05/2016 - 07/2004
7Colorectal Neoplasms (Colorectal Cancer)
06/2017 - 01/2008
5Breast Neoplasms (Breast Cancer)
11/2017 - 07/2010
5Stomach Neoplasms (Stomach Cancer)
06/2017 - 09/2002
5Colonic Neoplasms (Colon Cancer)
11/2015 - 02/2008
5Melanoma (Melanoma, Malignant)
12/2012 - 10/2009
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 01/2004
4Nasopharyngeal Carcinoma
12/2012 - 05/2006
3Esophageal Squamous Cell Carcinoma
04/2013 - 10/2008
3Cystadenoma
01/2013 - 02/2009
3Virus Diseases (Viral Diseases)
04/2012 - 07/2004
2Lung Neoplasms (Lung Cancer)
01/2019 - 12/2017
2Liver Neoplasms (Liver Cancer)
01/2015 - 06/2003
2Hepatitis B
04/2012 - 09/2005
2Inflammation (Inflammations)
07/2010 - 05/2003
2Fibrosis (Cirrhosis)
06/2010 - 03/2006
2Liver Cirrhosis (Hepatic Cirrhosis)
06/2010 - 03/2006
2Body Weight (Weight, Body)
06/2009 - 03/2006
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
02/2009 - 09/2002
2Lymphoma (Lymphomas)
08/2005 - 06/2003
2Severe Acute Respiratory Syndrome
07/2004 - 10/2003
1Hematologic Neoplasms (Hematological Malignancy)
11/2018
1Skin Neoplasms (Skin Cancer)
09/2018
1Stroke (Strokes)
07/2018
1Hemorrhagic Stroke
07/2018

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2004
11MicroRNAs (MicroRNA)IBA
07/2018 - 01/2010
8Telomerase (Telomerase Reverse Transcriptase)IBA
10/2021 - 06/2002
7Biomarkers (Surrogate Marker)IBA
07/2018 - 05/2003
6Small Interfering RNA (siRNA)IBA
09/2015 - 09/2006
5Peptides (Polypeptides)IBA
01/2016 - 07/2010
5Messenger RNA (mRNA)IBA
01/2015 - 06/2002
5Indicators and Reagents (Reagents)IBA
09/2013 - 09/2002
5Phosphotransferases (Kinase)IBA
11/2012 - 01/2006
5EnzymesIBA
10/2009 - 01/2004
4Cadherins (E-Cadherin)IBA
01/2018 - 02/2008
4InterferonsIBA
04/2012 - 07/2004
4eIF-5A2IBA
05/2009 - 01/2008
3Cisplatin (Platino)FDA LinkGeneric
12/2017 - 10/2009
3Antiviral Agents (Antivirals)IBA
02/2016 - 04/2012
3Therapeutic UsesIBA
11/2015 - 09/2008
3Cyclin-Dependent Kinase Inhibitor p16IBA
10/2015 - 01/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2012 - 04/2011
3LipidsIBA
04/2012 - 09/2008
3Enhancer of Zeste Homolog 2 ProteinIBA
09/2010 - 07/2010
2Paclitaxel (Taxol)FDA LinkGeneric
10/2021 - 09/2021
2Long Noncoding RNAIBA
01/2018 - 10/2015
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
11/2017 - 08/2009
23' Untranslated Regions (3' UTR)IBA
05/2016 - 06/2010
2Oncogene Proteins (Oncogene Protein)IBA
01/2016 - 01/2014
2Cyclin-Dependent Kinase 2IBA
11/2015 - 06/2007
2Tumor Suppressor Protein p14ARF (p14ARF)IBA
10/2015 - 01/2015
2Interferon Type IIBA
06/2015 - 07/2004
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2015 - 08/2014
2Aldehyde DehydrogenaseIBA
01/2015 - 01/2014
2VaccinesIBA
01/2014 - 04/2012
2CateninsIBA
01/2014 - 05/2013
2CytokinesIBA
01/2014 - 04/2005
2Cyclin D1IBA
11/2013 - 12/2009
2Lysine (L-Lysine)FDA Link
01/2011 - 01/2011
2Histones (Histone)IBA
01/2011 - 01/2011
2Glucose (Dextrose)FDA LinkGeneric
06/2010 - 06/2009
2Endoplasmic Reticulum Chaperone BiPIBA
06/2010 - 09/2009
2ErbB Receptors (EGF Receptor)IBA
11/2009 - 09/2008
2TNF-Related Apoptosis-Inducing LigandIBA
08/2009 - 08/2005
2Folic Acid (Vitamin M)FDA LinkGeneric
08/2009 - 03/2008
2poly(ethylene glycol)-co-poly(ethyleneimine)IBA
08/2009 - 03/2008
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2008 - 01/2006
2Complementary DNA (cDNA)IBA
02/2008 - 08/2004
2Protein Kinases (Protein Kinase)IBA
06/2007 - 01/2006
24- (5- (4- chlorophenyl)- 3- (trifluoromethyl)- 1H- pyrazol- 1- yl)benzenesulfonamideIBA
01/2006 - 09/2002
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2006 - 09/2002
2DNA (Deoxyribonucleic Acid)IBA
09/2005 - 08/2004
2Reactive Oxygen Species (Oxygen Radicals)IBA
07/2004 - 01/2004
2CatalaseIBA
07/2004 - 01/2004
1Flupenthixol (Flupentixol)IBA
01/2019
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2019
1Antipsychotic Agents (Antipsychotics)IBA
01/2019
1ForminsIBA
11/2018
1RafoxanideIBA
09/2018
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2018
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2018
1ibrutinibIBA
01/2018
1Untranslated RNA (Noncoding RNA)IBA
01/2018
1Antifungal AgentsIBA
12/2017
1EconazoleFDA LinkGeneric
12/2017

Therapy/Procedure

20Therapeutics
01/2018 - 06/2002
5Drug Therapy (Chemotherapy)
01/2018 - 06/2007
4Immunotherapy
09/2013 - 04/2005
3Radiotherapy
01/2017 - 06/2007
2Chemoradiotherapy
04/2013 - 07/2010
2Intraperitoneal Injections
10/2009 - 03/2006
2Aftercare (After-Treatment)
06/2009 - 01/2004